Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

Castera L, Vergniol J, Foucher J, Le BB, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343-350.

Publication Type:

Journal Article

Authors:

Castera, L.; Vergniol, J.; Foucher, J.; Le, Bail B.; Chanteloup, E.; Haaser, M.; Darriet, M.; Couzigou, P.; V de Ledinghen

Source:

Gastroenterology, Volume 128, Issue 2, p.343-350 (2005)

Keywords:

Aspartate Aminotransferases, Aspartate Transaminase, Biological Markers, Biopsy, blood, Comparative Study, diagnosis, Elasticity, Female, Fibrosis, France, H, hepatitis, Hepatitis C, Hepatitis C,Chronic, Humans, Liver, Liver Cirrhosis, Male, methods, Middle Aged, Paris, pathology, Patients, Roc Curve

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/15685546

Export Citation:

RIS Format

Top